JPMorgan Chase & Co. Cuts Coloplast A/S (OTCMKTS:CLPBY) Price Target to 980.00

Coloplast A/S (OTCMKTS:CLPBY – Get Rating) had its price objective trimmed by JPMorgan Chase & Co. from 1,014.00 to 980.00 in a research report released on Tuesday, The Fly reports. The brokerage currently has a neutral rating on the stock.

Other analysts have also recently issued reports about the stock. DNB Markets raised shares of Coloplast A/S from a sell rating to a hold rating in a research note on Wednesday, January 26th. Barclays upped their target price on shares of Coloplast A/S from 975.00 to 990.00 in a research report on Monday, January 10th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of Hold and a consensus target price of $1,038.00.

OTCMKTS CLPBY opened at $12.10 on Tuesday. The stock has a market cap of $26.14 billion, a P/E ratio of 40.33 and a beta of 0.28. The company’s 50-day simple moving average is $14.32 and its 200 day simple moving average is $15.38. Coloplast A/S has a twelve month low of $11.71 and a twelve month high of $18.90. The company has a quick ratio of 0.90, a current ratio of 1.29 and a debt-to-equity ratio of 0.02.

The firm also recently announced a dividend, which will be paid on Monday, May 23rd. Investors of record on Monday, May 16th will be given a $0.0455 dividend. This represents a yield of 1.54%. The ex-dividend date of this dividend is Friday, May 13th. Coloplast A/S’s dividend payout ratio (DPR) is currently 73.33%.

Coloplast A/S Company Profile (Get Rating)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.

Read More